Global TEVAR Market 2016-2020

Outlook of the global TEVAR market

Technavio’s market research analyst predicts the thoracic endovascular aneurysm repair (TEVAR) market to grow steadily at a CAGR of around 9% during the forecast period. The advent of minimally invasive surgeries (MIS) for TEVAR is a critical factor that fosters growth in this market. MIS has revolutionized the field of surgery and is widely used for performing cardiac surgeries that involve the insertion of stent grafts, occluders, and cardiac rhythm management devices. Since MIS involves making smaller incisions for operations,  it can reduce hospital stay and prevent excessive blood loss by the rapid healing of surgical site. With the increasing utilization of MIS for TEVAR, the demand for essential medical devices will increase. This increase in the demand for medical devices for the surgery will impel the prospects for market growth until 2020.

The growing popularity of robotic-assistance cardiac surgery is expected to boost market growth during the forecast period. Robotic surgical procedures help to reduce hospital stays and facilitate better cost management. Moreover, these procedures ensure surgical precision, improved outcomes, faster recovery periods, and reduced pain and discomfort. Growing awareness about the potential benefits of robotic surgeries among patients and surgeons will compel health care facilities to install and implement such equipment.

Geographical segmentation of the TEVAR market

• Americas
• APAC
• Europe
• MEA